keyword
https://read.qxmd.com/read/37930933/autoimmune-anti-d-in-an-rhd-positive-young-infant-learning-from-a-rare-case
#1
JOURNAL ARTICLE
Sheetal Malhotra, Manisha Roy, Disha Parchure, Munira Kaba, Ashish Jain, Swati Kulkarni, Deepak Bansal, Ratti Ram Sharma
BACKGROUND AND OBJECTIVES: Anti-D is usually immune in nature and is formed in individuals lacking D antigen or having variants/altered D phenotypes. In the Indian population, 93.8% are RhD positive, and R1 R1 is the commonest Rh phenotype. Here we report a rare and interesting case of autoimmune anti-D in an RhD-positive 3-month-old infant leading to warm autoimmune haemolytic anaemia. STUDY DESIGN AND METHODS: Auto-anti-D was detected serologically by immunohaematological techniques such as direct antiglobulin test, antibody detection and identification, dithiothreitol, enzyme treatment, antibody titration and elution...
November 6, 2023: Vox Sanguinis
https://read.qxmd.com/read/37867314/prevalence-of-red-blood-cell-alloantibodies-among-blood-donors-in-the-french-military-blood-institute-a-10-year-retrospective-study
#2
JOURNAL ARTICLE
Sandrine Pons, Laurence Poirrier, Estelle Fleuriot, Christophe Martinaud
BACKGROUND AND OBJECTIVES: Screening for red blood cell alloantibodies (RBC-Ab) is a critical step in ensuring blood transfusion safety performed by blood donation screening laboratories. We aim to evaluate the prevalence of the RBC-Ab among healthy blood donors. MATERIALS AND METHODS: Antibody screening of serum of all voluntary blood donors was performed as a routine immune-haematological procedure by a solid-phase method on a fully automated immunohaematology analyser...
October 22, 2023: Vox Sanguinis
https://read.qxmd.com/read/37689387/detection-of-red-cell-alloantibody-prior-to-overflow-phenomenon-in-a-case-of-warm-aiha-secondary-to-chronic-lymphocytic-leukemia-and-myasthenia-gravis-a-case-report
#3
JOURNAL ARTICLE
Davood Bava, Vasanth Asirvatham, Saptarshi Mandal, Amit Kumar Rohilla, Siddharth Mittal
INTRODUCTION: Defects in the lymphoid system have been linked to immune dysregulation, which might explain why lymphoid neoplasms and immunological disorders tend to occur concurrently. Chronic Lymphocytic Leukemia (CLL), characterized by the accumulation of dysfunctional lymphocytes, is associated with autoimmune cytopenias such as autoimmune haemolytic anemia (AIHA). Detection of underlying alloantibody in warm AIHA, is challenging for any transfusion medicine specialist. This report highlights the significance of overflow phenonmenon in detection of alloantibody in a case of warm AIHA secondary to CLL and myasthenia gravis...
September 7, 2023: Transfusion Clinique et Biologique: Journal de la Société Française de Transfusion Sanguine
https://read.qxmd.com/read/37435611/47-th-annual-national-conference-of-indian-society-of-blood-transfusion-and-immunohaematology-isbti-transcon-2022-b-11-th-13-th-november-2022-jammu
#4
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
May 2023: Asian Journal of Transfusion Science
https://read.qxmd.com/read/37206282/sarcoidosis-as-an-unusual-cause-of-unexplained-pancytopenia
#5
JOURNAL ARTICLE
Caitlin Raymond, Sri Bharathi Kavuri, Faisal Rawas, Jayati Mallick, Juan Olano, Kirill A Lyapichev
No abstract text is available yet for this article.
May 2023: EJHaem
https://read.qxmd.com/read/37193527/immunohaematological-conundrums-in-obstetrics-from-transfusion-services-viewpoint-in-armed-forces-setup
#6
JOURNAL ARTICLE
Rajat Jagani, Satish Kumar, Amit Pawar, Ujjwal Dimri, Amit Kumar Biswas
BACKGROUND: Obstetrics as a speciality has a very long association with the transfusion services and poses its own set of immunohematological (IHL) challenges. A study was carried out to evaluate the spectrum of IHL issues in obstetrics in our setup and to suggest a way forward. METHODS: This study was carried out in a transfusion services setup catering to antenatal care (ANC) clientele in two tertiary-level health care setups. Samples were collected from all ANC patients requiring transfusion and patients reporting for Indirect Coombs Test (ICT)...
2023: Medical Journal, Armed Forces India
https://read.qxmd.com/read/37074146/epidemiological-and-clinical-features-therapeutic-strategies-and-outcomes-in-patients-with-hyperhaemolysis-a-systematic-review
#7
REVIEW
Jeremy W Jacobs, Laura D Stephens, Elizabeth S Allen, Thomas C Binns, Garrett S Booth, Jeanne E Hendrickson, Matthew S Karafin, Christopher A Tormey, Jennifer S Woo, Brian D Adkins
Hyperhaemolysis syndrome (HHS), a severe form of delayed haemolytic transfusion reaction most commonly described in patients with sickle cell disease (SCD), involves destruction of both donor and recipient red blood cells (RBCs). As the epidemiology and underlying pathophysiology have yet to be definitively elucidated, recognition can be challenging. We systematically reviewed PubMed and EMBASE to identify all cases of post-transfusion hyperhaemolysis and characterized the epidemiological, clinical and immunohaematological characteristics and treatments of HHS...
June 2023: British Journal of Haematology
https://read.qxmd.com/read/36931491/positive-direct-antiglobulin-tests-in-cancer-patients-on-immune-checkpoint-inhibitors-a-case-series-from-india
#8
JOURNAL ARTICLE
Suvro Sankha Datta, Dibyendu De
Tumour cells activate immune checkpoints such as programmed death receptor-1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) signalling pathways to inhibit T lymphocyte activation and thus escape from immune surveillance. Immune checkpoint inhibitors (ICPis) reactivate T lymphocytes to recognize cancer cells by blocking CTLA-4 or PD-1. Autoimmune haemolytic anaemia is a rare, but often severe, complication of ICPis. Therefore, we performed a retrospective clinical case review, including serologic, haematology, and biochemistry laboratory results, of three patients who developed autoantibodies to erythrocytes following treatment with pembrolizumab, an anti-PD-1 inhibitor...
March 15, 2023: Transfusion Clinique et Biologique: Journal de la Société Française de Transfusion Sanguine
https://read.qxmd.com/read/36484329/prevalence-of-adsorbed-a-antigen-onto-donor-derived-group-o-red-cells-in-children-following-stem-cell-transplantation-a-single-centre-evaluation
#9
JOURNAL ARTICLE
Kelly Cripps, Khushnuma Mullanfiroze, Annette Hill, Rachel Moss, Susanne Kricke
BACKGROUND AND OBJECTIVES: A group AB D-positive child presented 1 year after haematopoietic stem cell transplant (HSCT) from a group O D-negative donor as group A D-negative. Engraftment remained at 100% in white cell lineages. The reason for the unusual result was explored, and the scarcely reported phenomenon of adsorption of secreted antigen was considered. This study also investigated the prevalence of secreted antigen adsorbed onto donor-derived group O red blood cells (RBCs) in children after HSCT and defined a process for laboratory management...
December 9, 2022: Vox Sanguinis
https://read.qxmd.com/read/36427052/the-complexities-of-transfusion-reactions-coexistence-of-a-delayed-haemolytic-transfusion-reaction-and-post-transfusion-purpura
#10
JOURNAL ARTICLE
Joanna Czerwinski, Ana McCarthy, Denise Herbert, David Roxby, Magdalena Sobieraj-Teague
BACKGROUND AND OBJECTIVES: Immune-mediated acute or delayed transfusion reactions occur when there is immunological incompatibility between transfused blood products and recipient's antibodies. Acute haemolytic transfusion reactions occur within 24 h and are delayed after 24 h up to 10 days following transfusion, whereas post-transfusion purpura (PTP) typically occurs 7-10 days post-transfusion. We present a case of a previously transfused and recently post-partum female who developed both delayed haemolytic transfusion reaction (DHTR) and PTP...
November 25, 2022: Vox Sanguinis
https://read.qxmd.com/read/36202315/real-world-data-from-india-on-clinical-practices-in-the-management-of-autoimmune-haemolytic-anaemia-a-survey-based-cross-sectional-assessment
#11
JOURNAL ARTICLE
Sudipta Sekhar Das, Soumya Das, Shamee Shastry, Veena Shenoy, Saikat Mandal, Suvro Sankha Datta
BACKGROUND: Autoimmune haemolytic anaemia (AIHA) is a decompensated acquired haemolysis caused by the host's immune system acting against its own red cell antigens.The aim of this national survey is to capture real-world data of clinical practices in AIHAbycollecting responsesfrom clinical haematologists across India. METHODOLOGY: In this cross-sectional study, a structured, 26-question online survey was conductedin Indiaby few members of the special interest group in immunohaematology betweenJanuary to March, 2022...
October 3, 2022: Transfusion Clinique et Biologique: Journal de la Société Française de Transfusion Sanguine
https://read.qxmd.com/read/36124716/investigating-non-immune-haemolytic-transfusion-reactions-in-surgical-patients
#12
Sreethu Chand, Amita R, Debasish Gupta
OBJECTIVE: To perform a Root Cause Analysis (RCA) to identify the cause for Acute Haemolytic Transfusion Reaction (AHTR) in five patients who received red cell transfusions. BACKGROUND: The occurrence of red coloured urine following blood transfusion carries the possibility of an immune or non-immune mediated haemolytic transfusion reaction (HTR). Non-immune haemolysis can be due to thermal, osmotic, or mechanical injury to red blood cells. The authors report five cases of non-immune HTR that occurred in surgical patients in the peri-operative period...
December 2022: Transfusion Medicine
https://read.qxmd.com/read/36114660/guidance-for-transfusion-management-in-patients-receiving-magrolimab-therapy-anti-cd47-monoclonal-antibody
#13
JOURNAL ARTICLE
Michelle Tan, Nicole Zacher, Rae French, Marija Borosak, Samantha Lennard, Annette Le Viellez, Simon Benson, James Daly
Magrolimab (Hu5F9-G4) is a first-in-class anti-CD47 IgG4 monoclonal antibody, with potential applications in several malignancies including myelodysplastic syndrome. CD47 blockade in malignancy has been shown to promote antitumour effects. However, the ubiquity of CD47 on red blood cells can result in interference in pretransfusion immunohaematology investigations and hinder timely provision of red blood cell units, with potential to mask clinically significant alloantibodies. We reviewed the literature for pretransfusion interference seen with magrolimab and methods to circumvent potential issues, and sought to provide clinical and laboratory recommendations for safe local transfusion practices...
September 16, 2022: Internal Medicine Journal
https://read.qxmd.com/read/36102136/six-sigma-in-blood-transfusion-services-a-dream-too-big-in-a-third-world-country
#14
JOURNAL ARTICLE
Aikaj Jindal, Nandita Maini
BACKGROUND AND OBJECTIVES: Transfusion errors can occur anywhere from blood donation to final blood transfusion. They are a source of increased cost and patient mortality. Automated workflows can reduce transcription errors, but resource-poor centres still use semi-automated/manual method for testing including manual labelling of column agglutination cards/testing tubes. Missing out any details on these cards can lead to errors in reporting results, wastage and loss of resources and effort...
September 14, 2022: Vox Sanguinis
https://read.qxmd.com/read/36094915/evaluating-immunohaematological-profile-among-covid-19-active-infection-and-recovered-patients-in-ghana
#15
JOURNAL ARTICLE
Yatik Konlaan, Samuel Asamoah Sakyi, Kwame Kumi Asare, Prince Amoah Barnie, Stephen Opoku, Gideon Kwesi Nakotey, Samuel Victor Nuvor, Benjamin Amoani
INTRODUCTION: The rapid spread of COVID-19 has been a global public health problem and it is yet to be put under control. Active COVID-19 is associated with unrestrained secretion of pro-inflammatory cytokines and imbalances in haematological profile including anaemia, leukocytosis and thrombocytopaenia. However, the haematological profile and immune status following recovery from COVID-19 has not been recognized. We evaluated the immunohaematological profile among COVID-19 patients with active infection, recovered cases and unexposed healthy individuals in the Ashanti region of Ghana...
2022: PloS One
https://read.qxmd.com/read/35611383/application-of-blood-group-genotyping-by-next-generation-sequencing-in-various-immunohaematology-cases
#16
JOURNAL ARTICLE
Tae Yeul Kim, HongBi Yu, Minh-Trang Thi Phan, Ja-Hyun Jang, Duck Cho
Background: Next-generation sequencing (NGS) technology has been recently introduced into blood group genotyping; however, there are few studies using NGS-based blood group genotyping in real-world clinical settings. In this study, we applied NGS-based blood group genotyping into various immunohaematology cases encountered in routine clinical practice. Methods: This study included 4 immunohaematology cases: ABO subgroup, ABO chimerism, antibody to a high-frequency antigen (HFA), and anti-CD47 interference...
April 2022: Transfusion Medicine and Hemotherapy
https://read.qxmd.com/read/35490312/association-between-abo-blood-groups-and-type-2-diabetes-mellitus-a-meta-analysis
#17
Earl Adriane Cano, Marion Agatha Esguerra, Ariane Michaela Batausa, Jessica Rose Baluyut, Ria Cadiz, Hewmy Franci Docto, Jose Ramir Encabo, Reena Mae Gomez, Maria Gina Sadang
BACKGROUND: The role of ABO blood group goes beyond immunohaematology as there is accumulating evidence on its association to type 2 diabetes mellitus. However, findings regarding the relation have been contradictory and there is a need to determine the validity of claims. OBJECTIVE: Evaluate the susceptibility of ABO blood groups to type 2 diabetes mellitus. METHOD: The research design is a meta-analysis. An extensive search was done in PubMed, ScienceDirect, ResearchGate, and Google Scholar...
April 27, 2022: Current Diabetes Reviews
https://read.qxmd.com/read/35041777/external-quality-assessment-providers-services-appear-to-more-impact-the-immunohaematology-performance-of-laboratories-than-national-regulatory-and-economic-conditions
#18
JOURNAL ARTICLE
Christoph Buchta, Wim Coucke, Wolfgang Huf, Andrea Griesmacher, Mathias M Müller, Wolfgang R Mayr, Øystein Flesland, Constantina Politis, Johanna Wiersum-Osselton, Andrés Aburto, Tony Badrick, Lobna Bouacida, Marek Budina, Joseph A Duenas, Wolf-Jochen Geilenkeuser, André V P Guimarães, Ana Hecimovic, Markus Jutzi, Chang-Keun Lee, Young Ae Lim, Joy Mammen, Petra Magdolna Molnár, Azita Mokhtari, Giuseppa Morabito, Eduardo Muñiz-Diaz, Truscha Niekerk, Anja Pakkanen, Paola Pezzati, Razvan Popa, Erika Sárkány, Jean-Pascal Siest, Dhitiwass Suvagandha, Marc Thelen, Jenny Ullhagen, Dalius Vitkus, Günther F Körmöczi
OBJECTIVES: Medical laboratories may, at their own discretion, exceed but not undercut regulatory quality requirements. Available economic resources, however, may drive or hinder eagerness to exceed minimum requirements. Depending on the respective scopes of regulatory and economic framework conditions, differing levels of quality efforts to safeguard laboratory performance can be anticipated. However, this has not yet been investigated. METHODS: Immunohaematology external quality assessment (EQA) results collected by 26 EQA providers from their participant laboratories in 73 countries from 2004 to 2019 were evaluated...
February 23, 2022: Clinical Chemistry and Laboratory Medicine: CCLM
https://read.qxmd.com/read/35027835/dimethyl-fumarate-as-the-peripheral-blood-inflammatory-mediators-inhibitor-in-prevention-of-streptozotocin-induced-neuroinflammation-in-aged-rats
#19
JOURNAL ARTICLE
Danuta Wrona, Irena Majkutewicz, Grzegorz Świątek, Joanna Dunacka, Beata Grembecka, Wojciech Glac
PURPOSE: Intracerebroventricular-(ICV)-streptozotocin-(STZ)-induced neuroinflammation is a model of Alzheimer's disease (AD) compatible with the inflammation hypothesis of ageing ("inflammaging" state). Previously, we observed age-dependent (young vs aged) dimethyl fumarate (DMF)-induced anti-inflammatory and neuroprotective effects in the brain along with improvement in cognitive functions in rats with the ICV-STZ-induced model of AD. To evaluate whether DMF reduces neuroinflammation based on the peripheral inflammatory response inhibition, we determined peripheral inflammatory mediators in young and aged rats with the ICV-STZ-induced AD pathology following DMF therapy...
2022: Journal of Inflammation Research
https://read.qxmd.com/read/34974432/abo-blood-group-and-skin-cancers
#20
REVIEW
Khaldun Jacoub, Zaynab Al-Eisawi
Beside the role of ABO group in immunohaematology, there is accumulating evidence that the ABO blood group also plays a key role in various human disorders. The interest in blood groups and their association with disease stems from the awareness that blood group antigens are incredibly important components in the process of cell maturation and control. Studies have indicated a link between cancer and the ABO blood group. The appearance or disappearance of blood type antigens is now considered a hallmark of malignancy in many common cancers...
2022: Clinical Hemorheology and Microcirculation
keyword
keyword
38270
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.